- Home
- TREE vs KURA Comparison
TREE vs KURA Comparison
Compare TREE & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TREE
- KURA
- Stock Information
- Founded
- TREE 1996
- KURA 2014
- Country
- TREE United States
- KURA United States
- Employees
- TREE N/A
- KURA N/A
- Industry
- TREE Finance: Consumer Services
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TREE Finance
- KURA Health Care
- Exchange
- TREE Nasdaq
- KURA Nasdaq
- Market Cap
- TREE 482.0M
- KURA 561.9M
- IPO Year
- TREE N/A
- KURA N/A
- Fundamental
- Price
- TREE $37.20
- KURA $5.84
- Analyst Decision
- TREE Buy
- KURA Strong Buy
- Analyst Count
- TREE 8
- KURA 12
- Target Price
- TREE $64.13
- KURA $24.50
- AVG Volume (30 Days)
- TREE 247.4K
- KURA 1.3M
- Earning Date
- TREE 07-24-2025
- KURA 08-07-2025
- Dividend Yield
- TREE N/A
- KURA N/A
- EPS Growth
- TREE N/A
- KURA N/A
- EPS
- TREE N/A
- KURA N/A
- Revenue
- TREE $972,179,000.00
- KURA $67,991,000.00
- Revenue This Year
- TREE $11.20
- KURA $109.86
- Revenue Next Year
- TREE $7.39
- KURA $107.90
- P/E Ratio
- TREE N/A
- KURA N/A
- Revenue Growth
- TREE 51.96
- KURA N/A
- 52 Week Low
- TREE $33.50
- KURA $5.41
- 52 Week High
- TREE $62.49
- KURA $23.48
- Technical
- Relative Strength Index (RSI)
- TREE 53.69
- KURA 39.08
- Support Level
- TREE $35.36
- KURA $5.73
- Resistance Level
- TREE $36.95
- KURA $6.01
- Average True Range (ATR)
- TREE 1.25
- KURA 0.30
- MACD
- TREE 0.52
- KURA -0.09
- Stochastic Oscillator
- TREE 94.20
- KURA 3.68
About TREE LendingTree Inc.
LendingTree Inc. is a U.S.-based company that mainly operates an online loan marketplace. The company offers online tools and resources to help consumers find loans or other credit-based products, including mortgage loans, reverse mortgages, home equity loans, personal loans, auto loans, credit cards, student loans, small business loans, and various related products. It provides consumers with direct access to a wide array of lenders. The company has three reportable segments: Home, Consumer, and Insurance. It generates match fees by connecting consumers with lenders and closing fees from lenders when a transaction is finalized. The company conducts business solely in the United States.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.